 |
| 5625 Fishers Lane Office Building, Rockville, MD |
 |
| David Baker |
WASHINGTON, D.C. –– Holliday Fenoglio Fowler, L.P. (HFF) announces the sale and acquisition financing of 5625 Fishers Lane and 12735 Twinbrook Parkway, a two-building, Class A office and lab portfolio totaling 229,905 square feet in Rockville, Maryland.
The HFF team represented the seller, a joint venture between entities affiliated with Wealthcap and JBG SMITH Properties, and procured the buyer.
Additionally, working on behalf of the new owner, the HFF team arranged acquisition financing for the transaction.
 |
| Matt Nicholson |
Constructed in 2004 as a build-to-suit for the National Institutes of Health (NIH), the two properties house highly specialized lab/office buildouts that are critical to ongoing research needs of the NIH, which occupies the entire facility.
The properties are situated in the Montgomery County life science market, which includes the National Institute of Allergy and Infectious Diseases (NIAID) headquarters, a one-million-square-foot U.S. Department of Health and Human Services (HHS) installation, the U.S. Pharmacopedia headquarters and the NIH headquarters.
The Johns Hopkins Montgomery County campus and the University of Maryland Institute for Bioscience and Biotechnology Research are located nearby, and many large pharmaceutical firms, including GlaxoSmithKline, Sanofi and MedImmune, reside in the area surrounding the properties.
 |
| Andrew Weir |
Additionally, 5625 Fishers Lane and 12735 Twinbrook Parkway offer walkable Metro access providing service to downtown and the entire Washington, D.C. metropolitan area.
The HFF investment advisory team representing the seller included Jim Meisel, Andrew Weir, Matt Nicholson and David Baker.
HFF’s debt placement team representing the borrower consisted of Kevin MacKenzie, Cary Abod, Brian Torp and Jay Graham.
Wealthcap ranks among the leading real asset and investment managers in Germany.
With more than 30 years of expertise they secure access to high-quality properties in many attractive asset classes, which they translate into comprehensible offers for participation tailored to individual investment goals.
 |
| Jim Meisel |
Wealthcap develops structuring solutions to meet the special needs of professional investors as well as products for private clients.
To date around 235,000 shares in 150 investments have been subscribed.
JBG SMITH is an S&P 400 company that owns, operates, invests in and develops assets concentrated in leading urban infill submarkets in and around Washington, DC.
Our mixed-use operating portfolio comprises approximately 19 million square feet of high-quality office, multifamily and retail assets, 98% of which are Metro-served.
With a focus on placemaking, JBG SMITH drives synergies across the portfolio and creates amenity-rich, walkable neighborhoods.
 |
| Kevin MacKenzie |
JBG SMITH’s future development pipeline includes over 19 million square feet of potential development density. For additional information on JBG SMITH please visit www.jbgsmith.com.
 |
| Cary Abod |
CONTACTS:
KEVIN MACKENZIE
CA Lic. # 01898953
 |
| Brian Torp |
HFF Executive Managing Director
(949) 253-8800
JAMES MEISEL
MD Lic. #521313
HFF Senior Managing Director
(202) 533-2500
KRISTEN MURPHY
HFF Director, Public Relations
(617) 338-0990
